Ventricular tachycardia ablation as first line therapy: are we there yet?

Ventricular Tachycardia Ablation as First Line Therapy: Are We There Yet? LUIGI DI BIASE, M.D., Ph.D.,∗,†,‡,§ PASQUALE SANTANGELI, M.D.,∗,§,¶ J. DAVID BURKHARDT, M.D.,∗ and ANDREA NATALE, M.D.∗,‡,¶ From the ∗Texas Cardiac Arrhythmia Institute, St. David’s Medical Center, Austin, Texas, USA; †Albert Einstein College of Medicine at Montefiore Hospital, Bronx, New York, USA; ‡Department of Biomedical Engineering, University of Texas, Austin, Texas, USA; §Department of Cardiology, University of Foggia, Foggia, Italy; and ¶Division of Cardiology, Stanford University, Palo Alto, California, USA